Dr.Sandy EISEN Chief Medical Officer - Frontline Pharma Consulting London , UK

Dr. Eisen studied medicine at Cambridge University and at St Bartholomew's Hospital Medical School, London and qualified as a doctor in 1980.  He has spent 24 years working in senior government positions and senior management roles in the pharmaceutical industry.  This includes time as a UK and EU regulator at the MHRA and EMA, where he worked on all types of products in all therapeutic areas.  In 2011, Dr. Eisen set up his company Frontline Pharma Consulting Ltd which provides regulatory, medical and clinical advice and consulting services to a wide variety of client companies in all therapeutic areas. He also provide interim medical management for the pharmaceutical industry which includes periods working as Medical Director and Clinical Research Director for a leading EU Pharma Company. Lecturing experience on many topics of regulatory affairs and clinical research.  Teaching on clinical topics on many courses 1993-2013, University of Cardiff, Diploma in Pharmaceutical Medicine Course, WHO courses for regulators, and lectures at DIA and TOPRA meetings. More >>

Dr.Raymond Peter Munden London, UK

Dr Munden worked in the pharmaceutical research and development industry for more than 33 years, his last position being Head of Analytical Services Europe for GlaxoSmithKline.  He has an extensive knowledge of all aspects of pharmaceutical development, with expertise in analytical method development and validation, analytical equipment qualification, degradation chemistry studies, chemometrics and stability testing and management, for which he is an acknowledged expert.  He is now a Pharmaceutical Development Consultant and is a skilled in trainer in various aspects of Pharmaceutical Development and has also lectured on Pharmaceutical Analysis MSc courses.  He is a past Chairman of the Joint Pharmaceutical Analysis Group. More >>

Dr. Malcolm Ross Managing Director - Generapharm Consulting Basel, Switzerland

Dr. Malcolm Ross is the Managing Director of Generapharm specialising in training, project management, formulation and analytical development and QA/GMP in the Pharmaceutical industry. With over 30 years experience in the Pharmaceutical industry, the last 15 at corporate level, Malcolm has been intimately involved in strategy  planning and analysis, pipeline management and related activities. Technically, Malcolm specialized in the development of finished dosage forms from both the analytical and formulation aspects and was responsible for establishing R&D in several generic companies in different international environments. He is an acknowledged expert in pharmaceutical analysis and has had responsibility in areas of QA including worldwide auditing, validation and technology transfer. More >>

Peter Wittner Specialist in Generics - Interpharm Consultancy London , UK

Peter Wittner, B.Sc., is an independent consultant specialising in the commercial aspects of generics with more than 30 years’ pharmaceutical experience.  Interpharm works with new market entrants on generic commercial strategies, competitor intelligence and gaining EU-GMP approval, assists in business development for generic companies outside the EU that are trying to enter the market and acts as an agent for a CRO providing biostudies to the generic industry.  On the other side of the equation, Interpharm has also worked with originator companies that are looking at ways of defending their major brands from generic incursion or themselves considering entry in to the field of generics. More >>